African genomics research, services and development startup, 54gene recently announced its launch of the African Centre for Translational Genomics (ACTG).
The launch is an initiative that was created to expedite research on translational genomics by African scientists.
The research startup is building the first African DNA biobank in the world after it has raised a seed funding of US$4.5 million and participating in Google Launchpad Africa accelerator programmes and Y Combinator.
The next generation of genomic scientists from Africa would be empowered as a result of establishing the ACTG. It will see a re-investment in the health ecosystem on the African continent.
This will, in turn, make available, internships, grants, fellowships and training for medical research students.
The ACTG would fund its first under Genetic Heritage Study (NCD-GHS) Consortium a non-communicable disease.
Dr. Abasi Ene-Obong, Founder, 54gene said, “In continuation with our belief at 54gene that genetic research in Africa should be ethical and beneficial to the communities we serve, and that African scientists be at the forefront of new drug discoveries that benefit Africans and the world at large, we have set up the ACTG to harness translational genetic research across Africa,”
“The NCD-GHS study is our pilot effort under the ACTG that has the potential to rewrite the playbook of genomics research, where African scientists will be placed at the forefront of new drug discoveries for conditions that affect the health of not only Nigerians but greater Africa and the world,” Abasi added
Featured Image: mbbaglobal
Do you have a story that is worth featuring? Get in touch via info[at]cfamedia.com.ng
Don’t miss important articles during the week. Subscribe tofor updates.